Literature DB >> 10217262

Neuroprotective role of Na+/myo-inositol cotransporter against veratridine cytotoxicity.

T Yamashita1, A Yamauchi, A Miyai, M Taniguchi, T Yoshimine, M Tohyama.   

Abstract

Na+/myo-inositol cotransporter has been shown to protect cells from the perturbing effects of hypertonic stress by the accumulation of myo-inositol. Here we report a regulatory mechanism for the cotransporter. Induction of myo-inositol cotransporter mRNA was observed after exposure to veratridine, a voltage-gated sodium channel opener. The veratridine-elicited induction was inhibited when Na+ was eliminated from the bath, although calcium chelation failed to modify the gene expression. Veratridine evoked an accumulation of Na+ in the cells, which paralleled the abundance of the mRNA. These results strongly suggested that an increase in Na+ influx due to sodium channel opening affected transcription of the cotransporter gene. Activity of the myo-inositol cotransporter was also up-regulated after veratridine exposure. To clarify the possible roles of myoinositol accumulation under veratridine exposure, we next examined the neurotoxic effects of veratridine when myo-inositol uptake was blocked. Neither 30 microM veratridine nor 500 microM 2-O,C-methylene myo-inositol, a competitive inhibitor of myo-inositol, elicited apparent cytotoxicity. However, a combination of these agents markedly increased cytotoxicity in culture, suggesting that an adequate amount of myo-inositol was necessary when the cells were stimulated with veratridine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217262     DOI: 10.1046/j.1471-4159.1999.0721864.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family.

Authors:  Amy L Wilson-O'Brien; Nicola Patron; Suzanne Rogers
Journal:  BMC Evol Biol       Date:  2010-05-21       Impact factor: 3.260

2.  Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.

Authors:  Mark Schiebler; Karen Brown; Krisztina Hegyi; Sandra M Newton; Maurizio Renna; Lucy Hepburn; Catherine Klapholz; Sarah Coulter; Andres Obregón-Henao; Marcela Henao Tamayo; Randall Basaraba; Beate Kampmann; Katherine M Henry; Joseph Burgon; Stephen A Renshaw; Angeleen Fleming; Robert R Kay; Karen E Anderson; Phillip T Hawkins; Diane J Ordway; David C Rubinsztein; Rodrigo Andres Floto
Journal:  EMBO Mol Med       Date:  2015-02       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.